Clinical Trials Directory

Trials / Unknown

UnknownNCT03762538

The Effect of the ALDH2 Gene Polymorphism on the Propofol Potency for Inducing Loss of Consciousness

The Effect of the ALDH2 Gene Polymorphism on the Propofol Potency for Inducing Loss of Consciousness in Cardiac Patients: a Prospective Observational Study

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Shanghai Zhongshan Hospital · Academic / Other
Sex
Male
Age
50 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine whether ALDH2 gene polymorphisms (G/G, G/A A/A) have effect on the potency of propofol.

Conditions

Interventions

TypeNameDescription
DRUGPropofolPatients will be induced to unconsciousness using propofol intravenously.

Timeline

Start date
2019-02-01
Primary completion
2019-06-30
Completion
2019-12-31
First posted
2018-12-03
Last updated
2018-12-03

Source: ClinicalTrials.gov record NCT03762538. Inclusion in this directory is not an endorsement.